ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 356 filers reported holding ENCOMPASS HEALTH CORP in Q3 2019. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,645,410 | +1.1% | 173,398 | +1.9% | 0.28% | +9.5% |
| Q2 2023 | $11,516,252 | -29.1% | 170,082 | -43.4% | 0.25% | -24.0% |
| Q1 2023 | $16,246,501 | +5.6% | 300,305 | +16.8% | 0.33% | -6.5% |
| Q4 2022 | $15,378,586 | +101.6% | 257,124 | +52.5% | 0.36% | +87.4% |
| Q3 2022 | $7,628,000 | +199.3% | 168,648 | +270.8% | 0.19% | +183.6% |
| Q2 2022 | $2,549,000 | +196.1% | 45,483 | +275.8% | 0.07% | +235.0% |
| Q1 2022 | $861,000 | +212.0% | 12,104 | +228.7% | 0.02% | +150.0% |
| Q3 2021 | $276,000 | -94.1% | 3,682 | -93.8% | 0.01% | -94.6% |
| Q2 2021 | $4,639,000 | +193.8% | 59,457 | +208.3% | 0.15% | +152.5% |
| Q1 2021 | $1,579,000 | +72.2% | 19,283 | +73.8% | 0.06% | +73.5% |
| Q4 2020 | $917,000 | -72.6% | 11,092 | -78.5% | 0.03% | -83.2% |
| Q3 2020 | $3,345,000 | +1116.4% | 51,474 | +1082.8% | 0.20% | +708.0% |
| Q3 2019 | $275,000 | – | 4,352 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARINGTON CAPITAL GROUP, L.P. | 76,809 | $4,155,367 | 5.68% |
| Paradice Investment Management LLC | 850,583 | $46,016,540 | 3.50% |
| BERNZOTT CAPITAL ADVISORS | 273,702 | $14,807,278 | 3.06% |
| Orchard Capital Management, LLC | 135,466 | $7,328,711 | 2.45% |
| Advantage Alpha Capital Partners LP | 202,232 | $10,940,751 | 2.28% |
| REINHART PARTNERS, LLC. | 746,588 | $40,390,419 | 2.19% |
| Magnetar Financial LLC | 1,917,030 | $103,711,323 | 2.02% |
| Leeward Investments, LLC - MA | 700,894 | $37,918,365 | 1.73% |
| HEARTLAND ADVISORS INC | 505,204 | $27,331,536 | 1.69% |
| Copeland Capital Management, LLC | 1,226,985 | $66,380 | 1.56% |